Record
Loading…
Record
Loading…
organization
Regeneron Pharmaceuticals is an American pharmaceutical company, headquartered in Tarrytown. Its CEO is Leonard S. Schleifer, since . It reported revenue of $14.34B for the period ended .
| fact | value | valid fromThe day the value took effect, not the day it was published. A period figure (a year's revenue) is dated at the period's end.More in About → | confidenceHow well the sources support the value, from 0 to 1. A single primary source is asserted from 0.7; nothing below 0.5 is asserted; a dead or disagreeing source lowers it.More in About → | sourcesPrimary: the entity's own filing, feed or site. Secondary: a publisher reporting it. Each claim links every source it has, with the passage that states the value where one was read.More in About → |
|---|---|---|---|---|
| quarterly net income | 1,948,700,000 United States dollar | sec.gov: 1 source for quarterly net income, claim clm_DEF587D6916A | ||
| quarterly operating income | 2,048,200,000 United States dollar | sec.gov: 1 source for quarterly operating income, claim clm_4585DB96888D | ||
| quarterly research and development | 1,794,700,000 United States dollar | sec.gov: 1 source for quarterly research and development, claim clm_4D8C13296D0A | ||
| quarterly revenue | 5,115,800,000 United States dollar | sec.gov: 1 source for quarterly revenue, claim clm_15BDC7B1496E | ||
| research and development | 5,850,200,000 United States dollar | sec.gov: 1 source for research and development, claim clm_1819F20C7CC4 | ||
| shares outstanding | 93,955,110 shares | sec.gov: 1 source for shares outstanding, claim clm_24C3500A1DEF | ||
| total equity | 33,498,500,000 United States dollar | sec.gov: 1 source for total equity, claim clm_24A29A7153C0 |
No dated events on the record yet.
Every claim on the timeline, including undated ones →"sameAs": ["https://www.wikidata.org/wiki/Q7308054", "https://asof.is/record/regeneron-pharmaceuticals"],
"identifier": { "@type": "PropertyValue", "propertyID": "asof", "value": "ent_regeneron-pharmaceuticals" }